BCAX — BICARA THERAPEUTICS INC
As of Q2 2026, 27 SEC-registered investment managers reported holding BCAX (BICARA THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $402.32M across 15.46M shares. That is -11.5% by share count (-2.02M shares) versus the previous quarter, while reported value moved +25.6%. Ownership is concentrated: the five largest holders account for 72.8% of reported value and the top ten for 88.5%.
Compared with the prior quarter, 1 opened new positions, 16 added to existing stakes, 10 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
BCAX is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 3.85M | $114.25M | 0.00% | Add |
| Janus Henderson Group history | Q1 2026 | 3.33M | $66.11M | 0.03% | Add |
| Franklin Resources history | Q2 2026 | 1.95M | $57.95M | 0.01% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 1.89M | $56.21M | 0.00% | Reduce |
| Vanguard Group history | Q4 2025 | 2.19M | $36.79M | 0.00% | Reduce |
| Geode Capital Management history | Q2 2026 | 1.16M | $34.53M | 0.00% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 1.02M | $29.81M | 0.00% | New |
| Wellington Management Group history | Q1 2025 | 1.39M | $18.17M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 520.57K | $15.46M | 0.00% | Reduce |
| D. E. Shaw & Co history | Q2 2026 | 498.19K | $14.79M | 0.01% | Add |
| Northern Trust Corp history | Q2 2026 | 396.34K | $11.77M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 365.48K | $10.85M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 352.90K | $10.48M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 302.94K | $8.99M | 0.00% | Reduce |
| Morgan Stanley history | Q2 2026 | 283.88K | $8.43M | 0.00% | Reduce |
| Millennium Management history | Q2 2026 | 262.25K | $7.79M | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 144.01K | $4.28M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 120.67K | $3.58M | 0.00% | Add |
| Manulife Financial history | Q2 2026 | 72.17K | $2.14M | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 65.99K | $1.96M | 0.00% | Reduce |
New Positions (Q2 2026)
- JPMorgan Chase & Co 1.02M sh · $29.81M
Fully Exited (vs previous quarter)
- Janus Henderson Group sold 3.33M sh · $66.11M
- Balyasny Asset Management sold 21.80K sh · $433.54K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | — | — | — | — | — | — | — | 1.26M | 1.34M | 2.11M | 2.31M | 2.53M | 2.84M | 3.85M |
| Franklin Resources | — | — | — | — | — | — | — | — | 13.67K | — | — | 1.62M | 1.62M | 1.95M |
| Fidelity Management & Research (FMR) | — | — | — | — | — | — | 2.27M | 2.12M | 3.61M | 2.54M | 2.70M | 3.35M | 2.10M | 1.89M |
| Geode Capital Management | — | — | — | — | — | — | 48.64K | 466.64K | 491.65K | 672.49K | 831.21K | 811.40K | 830.91K | 1.16M |
| JPMorgan Chase & Co | 7.80K | — | — | — | — | — | 730 | 64.74K | 21.79K | 27.46K | 24.93K | 16.85K | — | 1.02M |
| Goldman Sachs Group | — | — | — | — | — | — | 101.89K | 179.75K | 125.69K | 151.86K | 232.76K | 552.33K | 558.96K | 520.57K |
| D. E. Shaw & Co | — | — | — | — | — | — | — | — | — | — | — | 136.52K | 276.94K | 498.19K |
| Northern Trust Corp | — | — | — | — | — | — | — | 159.04K | 154.21K | 231.61K | 260.87K | 237.11K | 255.57K | 396.34K |
| Charles Schwab Investment Management | — | — | — | — | — | — | — | 156.78K | 153.00K | 193.05K | 280.88K | 272.14K | 263.99K | 365.48K |
| Bank of America Corp | — | — | — | — | — | — | 8.90K | 33.68K | 18.41K | 451.23K | 456.62K | 335.68K | 327.99K | 352.90K |
| Citadel Advisors | — | — | — | — | — | — | 234.12K | — | — | 221.52K | — | 796.86K | 1.73M | 302.94K |
| Morgan Stanley | — | — | — | — | — | — | 2.00K | 402.92K | 1.15M | 204.46K | 100.03K | 109.46K | 421.22K | 283.88K |
| Millennium Management | — | — | — | — | — | — | 299.56K | 385.41K | 25.65K | 741.02K | 1.01M | 434.70K | 156.70K | 262.25K |
| Deutsche Bank AG | — | — | — | — | — | — | — | 112.48K | 111.38K | 124.08K | 127.45K | 128.63K | 131.66K | 144.01K |
| BNY Mellon | — | — | — | — | — | — | — | 40.27K | 42.19K | 80.43K | 84.53K | 88.68K | 83.26K | 120.67K |
| Manulife Financial | — | — | — | — | — | — | 22.86K | 29.14K | 68.56K | 125.78K | 126.80K | 98.92K | 90.28K | 72.17K |
| UBS Group AG | — | — | — | — | — | — | 2.79K | 200.41K | 65.85K | 87.61K | 97.36K | 192.19K | 179.49K | 65.99K |
| Fidelity International (FIL) | — | — | — | — | — | — | 1.01M | 1.01M | 1.01M | 1.01M | 803.75K | 758.49K | 679.90K | 62.17K |
| Citigroup Inc | — | — | — | — | — | — | 252 | 15.49K | 17.46K | 11.52K | 656 | 66.70K | 9.59K | 50.24K |
| Two Sigma Investments | — | — | — | — | — | — | 9.00K | — | 12.77K | 134.46K | 95.24K | 98.48K | 89.88K | 46.61K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details